You Are Here: Home » Posts tagged with "Food and Drug Administration"
In a study scheduled for April publication in the American Journal of Epidemiology, a team of nine respected scientists from Harvard and the University of Michigan found that women who ate the most fish (more than 2 weekly servings) during the second...
The U.S. Food and Drug Administration has issued an import alert regarding entry of cantaloupe from Agropecuaria Montelibano, a Honduran grower and packer, because, based on current information, fruit from this company appears to be associated with a...
Stroke patients who use ibuprofen for arthritis pain or other conditions while taking aspirin to reduce the risk of a second stroke undermine aspirin’s ability to act as an anti-platelet agent, researchers at the University at Buffalo have shown.
The Hartz Mountain Corporation is voluntarily recalling a second specific lot of Hartz Vitamin Care for Cats due to concerns that bottles within the lot may have been potentially contaminated with Salmonella. Hartz is fully cooperating with the US Food...
ContraVac, Inc., a biotechnology company with reproductive and fertility focus, announces the U.S. Food and Drug Administration (FDA) has recently approved SpermCheck Vasectomy®, a simple diagnostic which confirms men’s post-vasectomy sterility....
Port St. Lucie, FL — February 28, 2008- Palo Alto Labs, 265 SW Port St. Lucie Blvd., Suite 252, Port St. Lucie, FL 34984, announced today that it is conducting a voluntary nationwide recall of the company’s supplement products sold under the...
The U.S. Food and Drug Administration approved Nexium (esomeprazole magnesium) for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease (GERD). The agency approved Nexium in two forms, a delayed-release capsule...
The U.S. Food and Drug Administration have announced that Brownwood Acres Foods Inc., Cherry Capital Services Inc. (doing business as Flavonoid Sciences) and two of their top executives have signed a consent decree that effectively prohibits the companies...
The U.S. Food and Drug Administration today licensed a treatment for hemophilia A, a rare, hereditary blood-clotting disorder that affects approximately 15,000 individuals, almost exclusively males, in the United States.